No headlines found.
No press releases found.
No news found.
The Fund seeks to match, at the end of the current Outcome Period, the share price returns of the iShares MSCI EAFE ETF (the "Underlying ETF"), up to a specified upside Cap, while providing a Buffer against the first 5% of Underlying ETF losses. The Cap and the Buffer will be reduced after taking into account management fees and other Fund fees and expenses. The Fund pursues a buffered strategy that seeks to match the share price returns of the iShares MSCI EAFE ETF (the "Underlying ETF") (i.e., the market price returns of the Underlying ETF), at the end of a three-month calendar quarter (i.e., from January 1 to March 31, April 1 to June 30, July 1 to September 30, or October 1 to December 31), as described below (the "Outcome Period"), subject to an upside maximum percentage return (the "Cap") and downside protection with a buffer against the first 5.00% of Underlying ETF losses (the "Buffer"). The Fund's intended return measured across different market conditions (e.g., rising or declining markets) is referred to as "outcomes" in this prospectus. The Underlying ETF's share price returns reflect the price at which the Underlying ETF's shares trade on the secondary market (not the Underlying ETF's net asset value).
Allianzim International Equity Buffer5 ETF trades on the BATS stock market under the symbol QBIV.
As of April 15, 2026, QBIV stock price declined to $26.24 with 2,252 million shares trading.
QBIV has a market cap of $5.90 million. This is considered a Sub-Micro Cap stock.
QBIV support price is $25.98 and resistance is $26.64 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that QBIV shares will trade within this expected range on the day.
